Main changes in diagnosis-related group payment model in the Russian Federation in 2026

The content and/or weight coefficients of Russian diagnosis-related groups (DRG) for inpatient and day care payment have been updated for 2026. Following clinical guidelines, changes were made in DRG for payment of therapy for malignant neoplasms in adults, intestinal infections and infections caused by polyresistant microflora. Six new groups were formed to pay for preimplantation genetic testing in fertilization in vitro (IVF). Weight coefficients of DRG for the treatment of chronic viral hepatitis B and C, for using genetically engineered biological agents and selective immunosuppressants, as well as IVF were recalculated. Three new groups were formed in medical rehabilitation profile. Accounting for the dose of normal human immunoglobulin in the treatment of complex neurological diseases was introduced.

Authors

Institutions

Publication Details

Journal
Medical Technologies Assessment and Choice
Published
2026-06-26
DOI
https://doi.org/10.17116/medtech20264802112
Primary Topic
Medical and Agricultural Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Main changes in diagnosis-related group payment model in the Russian Federation in 2026

M. Avxentyeva, К. В. Герасимова, A. V. Zuev, I.A. Zheleznyakova et al.
Medical Technologies Assessment and Choice
Medical and Agricultural Research Studies
article

Main changes in diagnosis-related group payment model in the Russian Federation in 2026

M. Avxentyeva, К. В. Герасимова, A. V. Zuev, I.A. Zheleznyakova, O.S. Plakhotnik, E.A. Sidorova, T.S. Vakhrusheva, Elizaveta Rumiantseva, A.S. Yakina, D.N. Kurilenkova, K.Yu. Buchneva
article en

Abstract

The content and/or weight coefficients of Russian diagnosis-related groups (DRG) for inpatient and day care payment have been updated for 2026. Following clinical guidelines, changes were made in DRG for payment of therapy for malignant neoplasms in adults, intestinal infections and infections caused by polyresistant microflora. Six new groups were formed to pay for preimplantation genetic testing in fertilization in vitro (IVF). Weight coefficients of DRG for the treatment of chronic viral hepatitis B and C, for using genetically engineered biological agents and selective immunosuppressants, as well as IVF were recalculated. Three new groups were formed in medical rehabilitation profile. Accounting for the dose of normal human immunoglobulin in the treatment of complex neurological diseases was introduced.

Medical Technologies Assessment and ChoiceVol. 48(2)
Russian Medical Academy of Continuous Professional Education (RU), Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" (RU)
Good health and well-being
Openalex Percentile: Top 2%
Medical and Agricultural Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.